TheraRadar
← Back
Data updated: Mar 29, 2026

SUPERPHARM

Infectious DiseaseOncologyCardiovascular
Generics

SUPERPHARM is a generic drug manufacturer focused on Infectious Disease, Oncology, Cardiovascular.

1981
Since
44
Drugs
-
Trials
478
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

DOXYCYCLINE HYCLATE 2026-02-19
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-13
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
PROPRANOLOL HYDROCHLORIDE 2026-01-27
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 25%
1 drugs Phase 3: 1 Phase 2: 2
Oncology 25%
0 drugs Phase 3: 3 Phase 1: 2
Cardiovascular 21%
2 drugs
Dermatology 19%
1 drugs Phase 3: 1 Phase 1: 1
Gastroenterology 11%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Dermatology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Oncology
CASPER PHARMA LLC big-pharma
Infectious Disease, Oncology, Cardiovascular, Gastroenterology, Dermatology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Oncology, Cardiovascular